drugset / Trial / NCT01582542

Desmopressin for Improving Nocturnal Enuresis in Patients After Radical Cystectomy With Bladder Reconstruction

NCT01582542

Phase 4 Unknown 50 enrolled Rabin Medical Center
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to prospectively assess whether Desmopressin, given for a period of month to patients after radical cystectomy with orthotopic bladder reconstruction, improves and lowers the rate of nocturnal enuresis.

Timeline

Start
2012-04
Primary completion
2013-12
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Desmopressin Peptide 0.1 mg

Indications